Latest in Transplantation

Reuters Health • The Doctor's Channel Daily Newscast

Immunosuppressive therapy “good” option for severe aplastic anemia

NEW YORK (Reuters Health) – The long-term survival of children with severe aplastic anemia who respond to immunosuppressive therapy with antithymocyte globulin and cyclosporine is “excellent, at about 90%,” based on a retrospective study conducted by researchers from the National Heart, Lung and...
Douglas P. Slakey, MD, MPH, Regents Professor and Chair, Department of Surgery, Tulane University School of Medicine, discusses the importance of organ donation and outcomes of organ transplantation. References and Resources National Institute of Transplantation Click Here to find info on...
Jorge D Reyes, MD, Director of Transplant Program Seattle Children’s Hospital and Regional Medical Center, discusses trends in immunosuppression and novel techniques in pediatric transplantation. References and Resources McCulloch MI, Gajjar P, Spearman CW, Burger H, Sinclair P, Savage L,...
12